Phase 2 Breast Cancer Trial, Not Yet Recruiting NCT07594678 Sponsor: Ohio State University Comprehensive Cancer Center Condition: Breast Cancer
Back to Breast Cancer

Phase 2 Breast Cancer Trial, Not Yet Recruiting

NCT07594678
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are patients at Ohio State University and are over 18 years old
  • People who have been diagnosed with breast cancer at stages I through IV
  • People who have been treated with a chemotherapy regimen that included either an anthracycline or a taxane (specific types of chemotherapy drugs)
  • People who have lost at least half of the hair on their scalp by the time of their final chemotherapy treatment
  • People who have used scalp cooling during treatment are not excluded from joining

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently pregnant or breastfeeding
  • People who have a history of scarring hair loss conditions (known medically as scarring/cicatricial alopecia) or a condition called alopecia areata
  • People who are known to have a sensitivity or allergic reaction to minoxidil
  • People who are currently being treated with a type of cancer therapy called an antibody-drug conjugate or immunotherapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026

Contact this trial

Principal Investigator: Brittany L Dulmage, MD, Ohio State University Comprehensive Cancer Center

Phone: 800-293-5066

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Ohio State University Comprehensive Cancer Center
Registry
ClinicalTrials.gov
Start date
2 July 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Dean scale score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov